The human liver plays a pivotal role in drug metabolism, largely attributable to the diverse family of UDP-glucuronosyltransferases (UGTs) that catalyse glucuronidation reactions. This conjugation ...

Some everyday medications can silently stress your liver. A hepatologist explains which drugs may raise liver enzymes and how ...

Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together ...

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

Animal studies show hope of an effective and safe treatment for the chronic liver condition affecting 25 percent of US adults.

Drug repurposing offers a promising and cost-effective strategy for developing new treatments. Metabolic ...

Eli Lilly’s blockbuster diabetes and obesity drug improved liver scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier this year. The study tested three ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a silent liver disease that is caused by fat buildup, inflammation ...

At the recent American Association of Clinical Endocrinology (AACE) annual meeting, leaders highlighted major advances in endocrine care, particularly around obesity and metabolic liver disease. In ...

High doses of cinnamon, especially in supplements or oils, may interfere with how the body metabolizes medications by activating or inhibiting liver enzymes. These interactions could make medications ...

The deal is the third acquisition since May involving a drug that could reverse liver scarring in people with metabolic dysfunction-associated steatohepatitis.